Literature DB >> 17406237

The counting Stroop: a cognitive interference task.

George Bush1, Paul J Whalen, Lisa M Shin, Scott L Rauch.   

Abstract

The counting Stroop is a validated Stroop task variant. Initially designed as a functional magnetic resonance imaging (fMRI) task for identifying brain regions subserving cognition and attention (dorsal anterior midcingulate cortex (daMCC) and dorsolateral prefrontal cortex (DLPFC)), it has been used to study cognition in healthy volunteers and to identify functional brain abnormalities in neuropsychiatric disorders, such as attention deficit hyperactivity disorder (ADHD). During the counting Stroop, subjects report by button-press the number of words (one to four) appearing on the screen, regardless of word meaning. Neutral-word control trials contain single semantic category common animals (e.g., 'dog' written three times), while interference trials contain number words that are incongruent with the correct response (e.g., 'two' written four times). The counting Stroop can be completed in approximately 20 min per subject and can be used offline (behavioral performance) or with fMRI, positron emission tomography, event-related potentials, magnetoencephalography or intracranial recordings.

Entities:  

Mesh:

Year:  2006        PMID: 17406237     DOI: 10.1038/nprot.2006.35

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  16 in total

Review 1.  Bayesian networks in neuroscience: a survey.

Authors:  Concha Bielza; Pedro Larrañaga
Journal:  Front Comput Neurosci       Date:  2014-10-16       Impact factor: 2.380

2.  Effect of craving induction on inhibitory control in opiate dependence.

Authors:  Antonio Verdejo-García; Dan I Lubman; Anne Schwerk; Kim Roffel; Raquel Vilar-López; Trudi Mackenzie; Murat Yücel
Journal:  Psychopharmacology (Berl)       Date:  2011-09-28       Impact factor: 4.530

3.  Altered fronto-cerebellar connectivity in alcohol-naïve youth with a family history of alcoholism.

Authors:  Megan M Herting; Damien Fair; Bonnie J Nagel
Journal:  Neuroimage       Date:  2010-10-21       Impact factor: 6.556

4.  Synergistic effects of marijuana abuse and HIV infection on neural activation during a cognitive interference task.

Authors:  Christina S Meade; Ryan P Bell; Sheri L Towe; Nan-Kuei Chen; Andrea L Hobkirk; Scott A Huettel
Journal:  Addict Biol       Date:  2018-09-21       Impact factor: 4.280

5.  The attenuation of dysfunctional emotional processing with stimulant medication: an fMRI study of adolescents with ADHD.

Authors:  Jonathan Posner; Tiago V Maia; Damien Fair; Bradley S Peterson; Edmund J Sonuga-Barke; Bonnie J Nagel
Journal:  Psychiatry Res       Date:  2011-07-22       Impact factor: 3.222

6.  Clinical correlates of attentional bias to drug cues associated with cocaine dependence.

Authors:  Ashley P Kennedy; Robin E Gross; Tim Ely; Karen P G Drexler; Clinton D Kilts
Journal:  Am J Addict       Date:  2014-03-15

Review 7.  Functional MRI in ADHD: a systematic literature review.

Authors:  Yannis Paloyelis; Mitul A Mehta; Jonna Kuntsi; Philip Asherson
Journal:  Expert Rev Neurother       Date:  2007-10       Impact factor: 4.618

8.  An fMRI study of scientists with a Ph.D. in physics confronted with naive ideas in science.

Authors:  Geneviève Allaire-Duquette; Lorie-Marlène Brault Foisy; Patrice Potvin; Martin Riopel; Marilyne Larose; Steve Masson
Journal:  NPJ Sci Learn       Date:  2021-05-11

9.  Differential Effects of Single-Dose Escitalopram on Cognitive and Affective Interference during Stroop Task.

Authors:  Christoffer Rahm; Benny Liberg; Maria Kristoffersen-Wiberg; Peter Aspelin; Mussie Msghina
Journal:  Front Psychiatry       Date:  2014-02-25       Impact factor: 4.157

10.  Unstable prefrontal response to emotional conflict and activation of lower limbic structures and brainstem in remitted panic disorder.

Authors:  Natalya Chechko; Renate Wehrle; Angelika Erhardt; Florian Holsboer; Michael Czisch; Philipp G Sämann
Journal:  PLoS One       Date:  2009-05-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.